Johnson Controls International (JCI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jun, 2026Executive summary
Q3 2024 sales rose 1% year-over-year to $7.2B, with 3% organic growth and GAAP net income of $975M; results exceeded most targets, driven by strong service and data center demand.
Announced divestitures of Residential & Light Commercial HVAC and Air Distribution Technologies, representing ~20% of sales, to simplify the portfolio and accelerate capital return.
CEO succession plan initiated and Board refreshment continued, including new director Patrick Decker.
Record Building Solutions backlog reached $12.9B, up 10% year-over-year, providing strong revenue visibility.
$750M PFAS-related settlement reached, with $351M insurance recovery recorded; restructuring and impairment costs totaled $106M.
Financial highlights
Q3 net sales were $7.2B (up 1% year-over-year); organic sales up 3%.
Adjusted EPS was $1.14, up 11% year-over-year; GAAP EPS was $1.45.
Free cash flow improved to $922M in Q3; adjusted free cash flow YTD reached $1.3B.
Net debt to adjusted EBITDA was 2.3x as of June 30, 2024; total debt $10.4B, cash $862M.
Gross margin for Q3 was 34.4%, up 30 bps year-over-year.
Outlook and guidance
Q4 2024 organic sales expected to grow ~7%, with segment EBITDA margin of ~19% and adjusted EPS of $1.23–$1.26.
Full-year adjusted EPS guidance tightened to $3.66–$3.69; organic sales growth of ~3% and segment EBITDA margin expansion of ~110 bps expected.
Adjusted free cash flow conversion expected at ~85%+ for FY24.
Economic softness in China expected to persist, impacting Asia Pacific results.
Additional restructuring charges anticipated as part of ongoing cost initiatives.
Latest events from Johnson Controls International
- Q4 organic sales up 10%, margin expansion, record backlog, and strong FY25 outlook.JCI
Q4 20248 Jun 2026 - Q1 2025 saw 10% organic growth, 39% EPS gain, and raised full-year guidance.JCI
Q1 20258 Jun 2026 - Q2 2025 saw 7% organic sales growth, margin expansion, and raised FY25 guidance.JCI
Q2 20258 Jun 2026 - Q3 saw 6% organic sales growth, record backlog, and expanded share repurchase authorization.JCI
Q3 20258 Jun 2026 - Record backlog, strong execution, and robust capital returns set up double-digit EPS growth in 2026.JCI
Q4 20258 Jun 2026 - Sales, EPS, and backlog hit records, with raised FY26 guidance and strong demand across regions.JCI
Q1 20268 Jun 2026 - Q2 saw 8% sales growth, 45% adjusted EPS growth, and record backlog, prompting raised guidance.JCI
Q2 20268 Jun 2026 - Innovation and operational excellence drive high single-digit organic growth and service expansion.JCI
Analyst Day 20265 Jun 2026 - Strong order growth, margin gains, and strategic focus drive optimism for future performance.JCI
19th Annual Global Transportation & Industrials Conference20 May 2026